Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 1592  

    Article Cited by others


Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients

Natarajan Aravintho, Agrawal Archi, Murthy Vedang, Bakshi Ganesh, Joshi Amit, Purandare Nilendu, Shah Sneha, Puranik Ameya, Rangarajan Venkatesh

Year : 2019| Volume: 18| Issue : 3 | Page no: 244-250

   This article has been cited by
1 Clinical Impact of PET Imaging in Patients With Metastatic Prostate Cancer
Murat Tuncel,Meltem Çaglar Tuncali,Tugçe Telli,Mustafa Erman
Clinical Nuclear Medicine. 2020; 45(10): 757
[Pubmed]  [Google Scholar] [DOI]
2 A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer
Inki Lee,Ilhan Lim,Byung Hyun Byun,Byung Il Kim,Chang Woon Choi,Sang-Keun Woo,Kyo Chul Lee,Joo Hyun Kang,Hee Seup Kil,Chansoo Park,Dae Yoon Chi,Jongwook Park,Kanghyon Song,Sang Moo Lim
European Journal of Nuclear Medicine and Molecular Imaging. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article